Cite
Thrombospondin-1 Silencing Improves Lymphocyte Infiltration in Tumors and Response to Anti-PD-1 in Triple-Negative Breast Cancer
MLA
Guillaume Labrousse, et al. “Thrombospondin-1 Silencing Improves Lymphocyte Infiltration in Tumors and Response to Anti-PD-1 in Triple-Negative Breast Cancer.” Cancers, vol. 13, Aug. 2021, p. 4059. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c7f8ba14f107123d6d4579aa96b25044&authtype=sso&custid=ns315887.
APA
Guillaume Labrousse, Julie Tenet, Hervé Prats, Justine Noujarède, Stéphanie Delmas, Bruno Ségui, Maud Chusseau, Thomas Farge, Elie Marcheteau, Florence Dalenc, Caroline Imbert, Florence Cabon, Camille Franchet, Céline Colacios, Michaël Pérès, & Raphaëlle Duprez-Paumier. (2021). Thrombospondin-1 Silencing Improves Lymphocyte Infiltration in Tumors and Response to Anti-PD-1 in Triple-Negative Breast Cancer. Cancers, 13, 4059.
Chicago
Guillaume Labrousse, Julie Tenet, Hervé Prats, Justine Noujarède, Stéphanie Delmas, Bruno Ségui, Maud Chusseau, et al. 2021. “Thrombospondin-1 Silencing Improves Lymphocyte Infiltration in Tumors and Response to Anti-PD-1 in Triple-Negative Breast Cancer.” Cancers 13 (August): 4059. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c7f8ba14f107123d6d4579aa96b25044&authtype=sso&custid=ns315887.